Daniel Osula
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,082 | 303 | 98.3% |
| Education | $89.96 | 11 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $859.32 | 71 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $736.33 | 42 | $0 (2024) |
| Boston Scientific Corporation | $459.39 | 15 | $0 (2024) |
| Antares Pharma, Inc. | $448.34 | 25 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $440.42 | 28 | $0 (2024) |
| ABBVIE INC. | $384.56 | 25 | $0 (2024) |
| PFIZER INC. | $316.89 | 16 | $0 (2024) |
| Allergan, Inc. | $191.79 | 12 | $0 (2022) |
| Supernus Pharmaceuticals, Inc. | $146.58 | 8 | $0 (2023) |
| Medtronic, Inc. | $114.17 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,456 | 78 | Sumitomo Pharma America, Inc. ($396.10) |
| 2023 | $1,399 | 85 | Sumitomo Pharma America, Inc. ($340.23) |
| 2022 | $1,195 | 79 | Astellas Pharma US Inc ($254.99) |
| 2021 | $875.61 | 58 | Astellas Pharma US Inc ($296.39) |
| 2020 | $246.94 | 14 | Boston Scientific Corporation ($76.84) |
All Payment Transactions
314 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: UROLOGY | ||||||
| 12/11/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Oncology | ||||||
| 12/09/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: UROLOGY | ||||||
| 12/04/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 12/03/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $30.13 | General |
| Category: Oncology | ||||||
| 11/21/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/19/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: UROLOGY | ||||||
| 11/17/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/12/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $25.80 | General |
| Category: ONCOLOGY | ||||||
| 11/11/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/28/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: UROLOGY | ||||||
| 10/15/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: UROLOGY | ||||||
| 10/15/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $8.86 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/03/2024 | Boston Scientific Corporation | Rezum Generator (Device) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: rezum_URO | ||||||
| 10/02/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: HORMONE THERAPY | ||||||
| 09/26/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/24/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $28.22 | General |
| Category: UROTHELIAL CANCER | ||||||
| 09/18/2024 | PFIZER INC. | XTANDI (Drug), TALZENNA, ORGOVYX | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: ONCOLOGY | ||||||
| 09/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: Oncology | ||||||
| 09/13/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: UROLOGY | ||||||
| 09/12/2024 | Boston Scientific Corporation | Rezum Generator (Device) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: rezum_URO | ||||||
| 09/10/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 09/05/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Oncology | ||||||
| 08/29/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/28/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,822 | 2,660 | $279,318 | $117,686 |
| 2022 | 32 | 2,192 | 4,244 | $353,049 | $177,709 |
| 2021 | 32 | 2,375 | 5,460 | $407,907 | $227,338 |
| 2020 | 12 | 564 | 719 | $59,728 | $32,710 |
All Medicare Procedures & Services
99 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 230 | 371 | $61,215 | $31,820 | 52.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 247 | 350 | $42,000 | $21,752 | 51.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 139 | 139 | $24,325 | $15,523 | 63.8% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 73 | 82 | $24,600 | $14,066 | 57.2% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 41 | 41 | $13,940 | $3,902 | 28.0% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 11 | 11 | $15,950 | $3,435 | 21.5% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 19 | 19 | $4,940 | $3,326 | 67.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 44 | 44 | $5,500 | $3,102 | 56.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 33 | 33 | $6,320 | $3,054 | 48.3% |
| 74018 | X-ray of abdomen, 1 view | Office | 2023 | 63 | 100 | $5,500 | $1,984 | 36.1% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 183 | 276 | $26,220 | $1,960 | 7.5% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 88 | 104 | $4,992 | $1,861 | 37.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 412 | 781 | $8,982 | $1,687 | 18.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 13 | 13 | $3,265 | $1,666 | 51.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 13 | $2,990 | $1,429 | 47.8% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 15 | 17 | $14,400 | $1,398 | 9.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 11 | 20 | $2,409 | $1,113 | 46.2% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 11 | 25 | $3,000 | $1,044 | 34.8% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 21 | 37 | $2,146 | $935.73 | 43.6% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 17 | 24 | $2,258 | $913.20 | 40.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 96 | 105 | $1,025 | $882.00 | 86.0% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 29 | 29 | $1,392 | $548.68 | 39.4% |
| J1335 | Injection, ertapenem sodium, 500 mg | Office | 2023 | 13 | 26 | $1,950 | $282.18 | 14.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 210 | 353 | $58,245 | $31,132 | 53.4% |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | Office | 2022 | 49 | 728 | $32,760 | $25,518 | 77.9% |
About Daniel Osula
Daniel Osula is a Student in an Organized Health Care Education/Training Program healthcare provider based in Huntsville, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/14/2014. The National Provider Identifier (NPI) number assigned to this provider is 1457770851.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Daniel Osula has received a total of $5,172 in payments from pharmaceutical and medical device companies, with $1,456 received in 2024. These payments were reported across 314 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($5,082).
As a Medicare-enrolled provider, Osula has provided services to 6,953 Medicare beneficiaries, totaling 13,083 services with total Medicare billing of $555,443. Data is available for 4 years (2020–2023), covering 99 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Location Huntsville, AL
- Active Since 04/14/2014
- Last Updated 02/04/2026
- Taxonomy Code 390200000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1457770851
Products in Payments
- GEMTESA (Drug) $632.15
- BOTOX (Biological) $474.25
- XIAFLEX (Biological) $441.00
- Myrbetriq (Drug) $417.67
- XTANDI (Drug) $401.65
- ORGOVYX (Drug) $259.50
- XYOSTED (Drug) $254.13
- LithoVue (Device) $231.83
- NOCDURNA (Drug) $194.21
- TLANDO (Drug) $146.58
- Xtandi (Drug) $145.26
- INTERSTIM (Device) $114.17
- PROLARIS (Device) $113.87
- JELMYTO (Drug) $108.23
- LUPRON DEPOT (Drug) $102.10
- MYRBETRIQ (Drug) $82.84
- Rezum Generator (Device) $77.92
- PROVENGE (Drug) $71.74
- ELIGARD (Drug) $68.59
- LITHOVUE (Device) $65.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Huntsville
James Mcmurtrie, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $53,619
Prasanna Allada, M.b.b.s., Mph, M.d, M.B.B.S., MPH, M.D
Student in an Organized Health Care Education/Training Program — Payments: $17,769
Dr. John Kostrzewa, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $16,188
Sravya Chirumamilla, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $8,357
Kathleen Hesterman, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $6,961
Dr. Ryan Black, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $6,514